Ir al contenido principal
5 mg vial lyophilised vial of Tesamorelin, ISO/IEC 17025 lab-verified, Peptyds packaging
Sistemas metabólicos
Sistemas
Tesamorelin
Investigación en hormona de crecimiento hipofisaria
Control de calidad europeoPureza ≥ 98 % verificada en laboratorio
Sistemas metabólicos
Premium · raro en la UE

Tesamorelin

Tesamorelin es un análogo sintético de GHRH de 44 aminoácidos, sintetizado con una modificación de ácido trans-3-hexenoico, estudiado en investigación de grasa visceral por su papel en pulsar la GH hipofisaria y elevar el IGF-1.

Un análogo de GHRH estudiado por la reducción de grasa visceral y el apoyo a la composición corporal — usado en contextos metabólicos y de hormona de crecimiento bajo supervisión médica.

Control de calidad europeoPureza ≥ 98 % verificada en laboratorioCOA específico del lote

For Research Use Only — Not for Human Consumption.

This compound has EMA approval as a prescription therapeutic.

Sold for in vitro laboratory research only.

Therapeutic use requires a licensed prescriber.

Listed under the WADA 2026 Prohibited List.

Not for use by competitive athletes in sanctioned sports.

Tamaño
€69€8610 mg · IVA (VAT) incluido · €6.90 / mg
1
Disponibilidad
Delivered in 3–7 days (EU)
Conservación
Store 2–8 °C. Use reconstituted vial within 24 hours.
Se envía desde
European fulfilment centre, tracked express

Prueba de laboratorio, por lote

  • Analizado de forma independiente, por lote
  • Certificado de análisis disponible
  • Pureza e identidad documentadas
Para qué sirve este péptido

Investigación en hormona de crecimiento hipofisaria.

Tesamorelin (CAS 218949-48-5) es un análogo sintético de GHRH conjugado con ácido trans-3-hexenoico para mejorar la estabilidad metabólica. La investigación ha examinado sus efectos sobre la amplitud del pulso de GH, la elevación del IGF-1 y la reducción de grasa visceral. Fórmula C221H366N72O67S, PM 5135,89 g/mol.

Investigación enlazada
  • Falutz et al. — Efectos de un análogo de GHRH sobre el tejido adiposo visceral en ensayos clínicos
  • Grunfeld et al. — Tesamorelin y variables de lipodistrofia en enfermedad asociada al VIH

Solo contexto de investigación. No es consejo médico. Consulta a un profesional sanitario cualificado antes de usarlo.

Especificación
  • 5 mg de polvo liofilizado por vial
  • Reconstituir con agua bacteriostática antes de usar
  • Conservar liofilizado a 2–8 °C, proteger de la luz
  • Una vez reconstituido, usar en 24 horas
Qué llega en la caja
  • Un vial de Tesamorelin liofilizado de 5 mg
  • Tapón con precinto de seguridad y etiqueta con código de lote
  • Tarjeta de conservación con nota de consulta médica
Pharmacology

What the research reports about this molecule.

Classic parameters from peer-reviewed literature. Not human dosing guidance — read alongside the PubMed references on /learn.

Sequence
Análogo de GHRH de 44 aminoácidos
Molecular weight
5135 Da
Mechanism
Pulsa la GH hipofisaria
Research domain
Investigación en grasa visceral
Reconstitution
Agua bacteriostática, USP
Storage
Largo plazo -20 °C liofilizado; -80 °C para >12 meses; reconstituido 2–8 °C, ≤4 semanas
Cómo se usa

Pasos simples y deliberados — no un protocolo.

Estas son notas prácticas de manejo. Las decisiones de dosis quedan entre tu médico y tú.

  1. 1

    Reconstituir con 1 mL de agua bacteriostática justo antes de usar — usar en 24 horas

  2. 2

    Adminístralo por vía subcutánea según te indique tu médico

  3. 3

    No guardar el vial reconstituido; prepararlo fresco cada vez

Guía de uso

Lee el protocolo de investigación

Instrucciones breves de reconstitución, dosificación y manejo.

Calculadora de reconstitución

Solo para investigación

Jeringa

Péptido en el vial

Agua bacteriostática

Concentración5 mg/mL

Dosis objetivo

Carga la jeringa hasta

5

unidades · 0.05 mL

01020304050607080901005

Concentración

5

mg/mL

Dosis por vial

40

dosis

U-50 2.5 · U-40 2 unidades

Solo para cálculo de investigación de laboratorio. No es consejo médico ni de dosificación, y no es para uso humano ni veterinario.

Quienes investigan Peso / apoyo metabólico también comparan

Quality documentation
Batch-by-batch lab verification

Each release is matched with quality documentation through a documented verification path. Identity, purity, and composition test results sit on the product page before you buy.

Quality documentation
ISO/IEC 17025-accredited lab testing

Every batch is verified by an ISO/IEC 17025-accredited laboratory before release. Identity, purity, and documentation travel with the product — not behind a form.

Storage & shipping
Kept-cold commitment

Sensitive peptides ship in insulated cold packaging with gel packs sized for a 48-hour transit window, tracked door to door.

Preguntas, respondidas con claridad

Todo lo que vale la pena preguntar antes de pedir.

Envío, conservación, calidad y cuándo hablar con un médico — sin rodeos.

What proof of quality comes with my order?

Every batch ships with a batch code printed on the vial. The matching independent lab report — showing identity, purity, and composition — is linked on the product page and stays on your order page after purchase.

Should I speak to a clinician before using a peptide?

We recommend it — especially if you are pregnant, nursing, managing a medical condition, or combining peptides with prescribed medication. Our product pages are educational. They are not medical advice and they do not replace a conversation with a qualified practitioner.

When will my order ship and arrive?

Orders placed before 14:00 CET Monday–Friday ship the same business day from our European fulfilment centre in The Hague, Netherlands. Standard tracked EU delivery arrives in 2–4 business days; express options are available at checkout.

What does "research only" actually mean on a peptide label?

Research-only means the compound has not been approved by the EMA or any national medicines authority for medical use, and is sold solely for in-vitro and laboratory research. It is not a supplement, a cosmetic, or a medicine, and it carries no claims for human consumption.

What's the difference between a prescription peptide and a research peptide?

A prescription peptide (e.g. Wegovy, Mounjaro, Vyleesi, Zadaxin in the relevant jurisdictions) has been through EMA or national-authority review, carries an authorised indication, and is dispensed by a pharmacy against a script. A research peptide is a reference-grade compound sold for laboratory use only.

How do I reconstitute a lyophilised peptide vial?

Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.

How much bacteriostatic water should I add to my peptide vial?

The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.

How long does a reconstituted peptide stay stable in the fridge?

Most lyophilised peptides reconstituted with bacteriostatic water remain stable for 28–30 days at 2–8 °C, protected from light. A handful of short, fragile sequences — Epithalon among them — drop to roughly 14 days. Never freeze a reconstituted vial.

What side effects are most commonly reported across peptide research?

Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue. GLP-1 and dual-agonist class peptides add dose-dependent gastrointestinal effects.

Who should not use peptides?

Peptides are not appropriate for anyone who is pregnant, nursing, planning conception, under 18, managing active cancer, or on immunosuppressants — and competitive athletes governed by WADA must avoid every peptide on the prohibited list. Anyone with a personal or family history of melanoma should specifically avoid melanocortin-receptor agonists.